DrugDashboards

Market view

piperacillin and tazobactam · Injection, Powder, Lyophilized, For Solution

24 marketed package NDCs · 5 active manufacturers

Most dispensed: SODIUM 3 g/15mL; SODIUM .375 g/15mL · Injection, Powder, Lyophilized, For Solution · #10 vial, single-uses/carton / 15 ml in 1 vial, single-use · SODIUM 3 g/15mL; SODIUM .375 g/15mL · Injection, Powder, For Solution · #10 vial, single-doses/carton / 15 ml in 1 vial, single-dose · SODIUM 3 g/15mL; SODIUM .375 g/15mL · Injection, Powder, For Solution · #10 vial, single-doses/box / 15 ml in 1 vial, single-dose · SODIUM 3 g/15mL; SODIUM .375 g/15mL · Injection, Powder, Lyophilized, For Solution · #10 vial, single-doses/carton / 15 ml in 1 vial, single-dose

All formsInjection, Powder, Lyophilized, For Solution (24)Injection, Powder, For Solution (24)

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 10% over the past year, to $3.49 per unit. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$2.00$4.00$6.00Jul 2024Jul 202605companies actively selling

Latest · Jul 2026 — typical price $3.49 · middle half $3.49–$3.49 · full range $3.49–$3.49 · 4 products · 5 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per unitⓘSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for piperacillin and tazobactam, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in beta Lactamase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Piperacillin and tazobactam in shortage right now?
No. FDA does not currently list Piperacillin and tazobactam in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Piperacillin and tazobactam?
11 companies have marketed Piperacillin and tazobactam in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • Planned discontinuation — Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)Jan 20, 2026

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.